| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BM Bert Miller Miller Wealth Advisors LLC | 6,000 | $720 | $840 | $120 | 16.67% |
| - Industry | - Sector | Ross Bjella CEO | OTC PINK Exchange | 488359100 CUSIP |
| US Country | 9 Employees | - Last Dividend | 5 Mar 2009 Last Split | - IPO Date |
Kelyniam Global, Inc. is a prominent medical device manufacturer that specializes in the production of custom prosthetic cranial implants. With a strong focus on utilizing advanced computer-aided design (CAD) and computer-aided manufacturing (CAM) techniques, the company processes medical-grade polymers to create precision solutions for patients within the United States. Initially named Ketner Global Investments, Inc., the entity underwent a rebranding to its current title in December 2007, signaling its dedicated pivot towards medical innovations. Founded in 2005 and headquartered in Collinsville, Connecticut, Kelyniam Global has established itself as a pivotal player in the medical sector, serving a diverse clientele that includes surgeons, health systems, and payers alike.
At the core of Kelyniam Global’s offerings are its bespoke medical devices, specifically tailored to each patient's unique anatomy and medical requirements.
These implants are designed using cutting-edge technology that allows for precision custom-fit solutions catered to the individual needs of patients requiring cranial restructuring. They are crafted utilizing advanced medical-grade polymers, ensuring both durability and biocompatibility.
Dedicated to the reconstruction of facial and cranial structures, these implants provide solutions for patients in need of facial structural repairs or enhancements. Like the cranial implants, these are also produced using high-quality polymers and state-of-the-art manufacturing processes for accurate fit and optimal performance.